Table 1 Clinical characteristics and outcomes of enrolled patients with pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa for a 6-month period from ten hospitals in Korea.

From: Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea

Variables

MRAB-P

n = 108

MRPA-P

n = 28

p value

Age (years) [mean, (± SD)]

69.4 (± 16.8)

67.0 (± 17.1)

0.508

Sex (male)

71 (65.7%)

16 (57.1%)

0.398

Location

Ward

38 (35.2%)

14 (50.0%)

 

Intensive care unit

68 (63.0%)

13 (46.4%)

Emergency room

2 (1.9%)

1 (3.6%)

Out-patient clinic

0

0

LOS (days) [mean, (± SD)]

73.2 (± 55.5)

92.6 (± 153.5)

0.516

Post pneumonia LOS [mean, (± SD)]

39.9 (± 45.0)

39.1 (± 37.6)

0.962

SOFA score (median, (IQR))

5 (2–8)

3 (1–7)

0.138

Severity of infection

No SIRS

13 (12.0%)

5 (17.9%)

0.140

Sepsis

61 (56.5%)

18 (64.3%)

Severe sepsis

12 (11.1%)

2 (7.1%)

Septic shock

22 (20.4%)

3 (10.7%)

Mortality

In hospital

42 (38.9%)

10 (35.7%)

0.758

7 days

4 (3.7%)

4 (14.3%)

0.056

30 days

26 (24.1%)

9 (32.1%)

0.384

90 days

40 (37.0%)

11 (39.3%)

0.827

  1. MRAB-P multidrug resistant A. baumannii pneumonia, MRPA-P multidrug resistant P. aeruginosa pneumonia, LOS length of stay, SD standard deviation, IQR interquartile range, SOFA sequential organ failure score.